Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product
Status:
Completed
Trial end date:
2021-02-02
Target enrollment:
Participant gender:
Summary
The study will be performed at a single site with 38 subjects. Participantswill take 2
tablets of the test product and reference product in 2 periods and 2 sequences (either test
after reference or reference after test). There will be a washout of at least 14 days between
each study period.